Durect Corporation Stock News

Gainers Cellect Biotechnology Ltd. (NASDAQ: APOP) shares jumped 45% to close at $3.03 on Wednesday. Cellect Biotechnology and Canndoc Ltd. agreed to enter into strategic pharma...

Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 3) * Acceleron Pharma Inc (NASDAQ: XLRN) * BioMarin

There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Antares Pharma (ATRS) and Durect (DRRX) with bullish

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Antares Pharma ( ATRS – Research Report ) and Durect ( DRRX – Research Report ) with bullish sentim

Gainers Ambarella (NASDAQ: AMBA) shares are trading higher after the company reported better-than-expected Q4 EPS and sales results. The company also issued Q1 sales...

DURECT Corporation (Nasdaq: DRRX) today announced financial results for the three months and year ended December 31, 2019 and provided a corporate update.

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 2) Forty Seven Inc (NASDAQ: FTSV )( announced a deal

Biotech stocks came under significant weakness along with the broader market in the week ended Feb. 28. Despite fears the COVID-19 epidemic will likely drag global growth, the viral outbreak proved ad

DURECT Corporation (Nasdaq: DRRX) today announced that it will report its fourth quarter and year ended December 31, 2019 financial results and host a conference call after the market close on Tuesday

With climate change becoming a major focus in Australia and around the world, leaders in the sustainability arena could become the big market winners.